GSK Related New Coverage
-
SocGen Starts GSK, NVS, SNY at Buy, AZN at Hold
-
Leerink Swann Starts Puma Biotechnology (PBYI) at Outperform; Act II Has a Familiar Story Line
-
UPDATE - UBS Initiates Coverage on Human Genome (HGSI) with a Neutral; See Stock Range-Bound as GSK Hovers
-
Leerink Swann Starts Anthera Pharma (ANTH) at Outperform; Compelling Risk-Reward with Advanced Programs in SLE and ACS
-
Two Brokerage Firms Step to the Plate - Initiate Human Genome Sciences (HGSI) With a "Buy"
-
Piper Jaffray Initiates Coverage on Theravance (THRX) with an Overweight; Relovair $3bn+ Sales Excluding US Asthma
-
Piper Jaffray Assumes Coverage on Human Genome Sciences (HGSI) with an Overweight; Benlysta's First Mover Advantage Key to $4bn+ Opportunity
-
Leerink Swann Initiates Coverage on GlaxoSmithKline (GSK) with a Market Perform
-
Deutsche Bank Initiates Coverage on GlaxoSmithKline (GSK) with a Hold; Poor growth, Rich Cash Flow
-
Barclays Starts NVO, SNY at Overweight, GSK, AZN at Equalweight, NVS at Underweight
-
Goldman Sachs Resumes Human Genome Sciences (HGSI) at Buy, Sees As Potential Takeover Target
-
Hapolim Securities Initiates Coverage on Targacept (TRGT) with a Buy
-
Benchmark Initiates Coverage on XenoPort (XNPT) with a Hold
-
Brean Murray Assumes Coverage on Adolor Corporation (ADLR) with a Buy; Believe in Partnerships & Market Potential
-
Soleil Securities Slaps A 'Sell' Rating on Valeant Pharmaceuticals (VRX)
-
Soleil Securities Initiates Coverage on Theravance (THRX) with a Hold
-
Credit Suisse Initiates Coverage on GlaxoSmithKline (GSK) with an Outperform
-
Jefferies & Co Initiates Coverage on GlaxoSmithKline (GSK) with a Buy
-
Piper Jaffray Initiates Coverage on XenoPort (XNPT) with a Buy
-
Susquehanna Initiates Coverage on Exelixis (EXEL) with a Positive
-
Susquehanna Initiates Coverage on Theravance (THRX) with a Positive
-
UBS Starts Glaxosmithkline (GSK) at Neutral
-
S&P Equity Research Initiates Coverage on Theravance (THRX) with a Buy
-
Citigroup Initiates Coverage on United Therapeutics Corp (UTHR) with a Buy
-
Citigroup Initiates Coverage on POZEN Inc (POZN) with a Buy
-
Cowen & Co Initiates Coverage on GlaxoSmithKline (GSK)
-
Morgan Stanley Stars THRX at Overweight
Back to GSK Stock Lookup
